2. Treatment for Acute Lymphoblastic Leukemia
نویسندگان
چکیده
منابع مشابه
Treatment of Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) affects both children and adults, with prevalence between the ages of 2 and 5 years. Serial clinical trials have resulted in steady improvement in the outcome of patients with ALL. Most children and over a third of adult patients are cured with widely available treatment approaches based on the use of risk-directed multiagent chemotherapy regimens and diligent...
متن کاملDiagnostic Advances for Improved Treatment of Childhood Acute Lymphoblastic Leukemia in Indonesia. Acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is the most curable disease among pediatric cancers. The success of ALL treatment is depending on: diagnostic accuracy, proper stratification, chemotherapy availability and supportive care including: infection control, isolation room, palliative care and psychology mentoring. Diagnostic of leukemia in Indonesia is not yet performed according to the WHO standar...
متن کاملTreatment of adult acute lymphoblastic leukemia.
Treatment results in adult acute lymphoblastic leukemia (ALL) have improved considerably in the past decade, with an increase of complete remission rates to 85% to 90% and overall survival rates to 40% to 50%. Superior chemotherapy and supportive care, the integration of stem cell transplantation (SCT) into frontline therapy, and optimized risk stratification were important developments. Even m...
متن کاملTreatment of pediatric acute lymphoblastic leukemia.
Acute lymphoblastic leukemia (ALL) is the most common pediatric oncologic diagnosis, and advances in its treatment have led to progressive improvements in survival. The 4 main components of therapy are remission induction, consolidation, maintenance, and central nervous system-directed therapy, and usually last 2 to 3 years. Treatment intensity based on risk-based stratification is the cornerst...
متن کاملBiology and treatment of acute lymphoblastic leukemia.
Acute lymphoblastic leukemia (ALL), the most common type of cancer in children, is a heterogeneous disease in which many genetic lesions result in the development of multiple biologic subtypes. Today, with intensive multiagent chemotherapy, most children who have ALL are cured. The many national or institutional ALL therapy protocols in use tend to stratify patients in a multitude of different ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 2013
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.102.1696